MCOMBRIAX
Live / Applied — Third extension granted (statement of use) (as of 13 Mar 2026)
What this means for you
Not registered yet, but its 14 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98602103
- Mark type
- Stylized text
- Filed
- 14 Jun 2024
- Published for opposition
- 20 Aug 2024
- Attorney of record
- John Francis Ward
Goods and services
- Class 005 — Pharmaceuticals: Vaccines for human use
Owner
- ModernaTx, Inc., Cambridge, MA, US
- ModernaTx, Inc., Cambridge, MA, US
Prosecution history
- 14 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2026 — SOU EXTENSION 3 GRANTED
- 13 Mar 2026 — SOU EXTENSION 3 FILED
- 13 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2025 — SOU EXTENSION 2 GRANTED
- 02 Oct 2025 — SOU EXTENSION 2 FILED
- 02 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Mar 2025 — SOU EXTENSION 1 GRANTED
- 25 Mar 2025 — SOU EXTENSION 1 FILED
- 25 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION